SOD2-Superoxide Metabolic Axis Regulates Mitophagy and Modulates TKIs Sensitivity in Head and Neck Squamous Cell

Wan-Hang Zhou1, Shuo-Jin Huang1, An-Xun Wang1

  • 1Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.

Cancer Science
|March 30, 2026
PubMed

Insights

Superoxide dismutase 2 (SOD2) impacts head and neck cancer (HNSCC) drug response. Targeting SOD2 and its related superoxide metabolism may enhance tyrosine kinase inhibitor (TKI) effectiveness in HNSCC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Superoxide dismutase 2 (SOD2) is linked to head and neck squamous cell carcinoma (HNSCC).
  • The precise role of SOD2 in regulating tumor response to tyrosine kinase inhibitors (TKIs) in HNSCC is not fully understood.
  • Investigating the mitochondrial superoxide-mitophagy pathway offers a potential mechanism.

Purpose of the Study:

  • To determine if SOD2 influences TKI sensitivity in HNSCC via a mitochondrial superoxide-mitophagy axis.
  • To elucidate the mechanistic link between SOD2, mitochondrial function, and mitophagy in HNSCC cells.
  • To evaluate the therapeutic potential of targeting the SOD2-superoxide axis for improving TKI efficacy.

Main Methods:

  • Bioinformatic analysis of SOD2 expression and mitophagy signatures in HNSCC.
  • In vitro functional experiments involving SOD2 silencing and pharmacological modulators (Mito-TEMPO, rotenone).
  • In vivo studies using SOD2 knockout xenograft models treated with TKIs.

Main Results:

  • Elevated SOD2 expression negatively correlated with mitophagy signatures in HNSCC.
  • SOD2 silencing caused mitochondrial superoxide accumulation, impaired function, and activated mitophagy.
  • SOD2 knockdown sensitized HNSCC cells to TKIs, an effect modulated by superoxide levels.
  • SOD2 knockout xenografts showed improved antitumor response to TKIs.

Conclusions:

  • SOD2 is a critical regulator of mitochondrial redox homeostasis and mitophagy in HNSCC.
  • The SOD2-superoxide metabolic axis significantly modulates HNSCC sensitivity to TKIs.
  • Targeting SOD2 and superoxide metabolism presents a promising strategy to enhance TKI efficacy in HNSCC.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
62
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K